ORR and DCR
PD
DISEASE, REMISSION, BEST
In the efficacy analysis, the investigators determined that 29 patients in the CIK-SOX group and 25 patients in the SOX group had measurable lesions. No patients in the CIK-SOX group achieved CR, while 16 patients achieved PR, and 11 patients achieved SD. The ORR was 55.2% (95% CI, 35.7–73.6%) and DCR was 93.1% (95% CI, 77.2–99.2%). In the SOX group, eight patients achieved PR and 14 patients achieved SD. The ORR and DCR were 32.0% (95% CI, 14.9–53.5%) and 88.0% (95% CI, 68.8–97.5%), respectively. The efficacy analysis results for all eligible patients are shown in Best overall response (Patients with measurable lesions).N: The total number of subjects in the treatment group. It is the denominator for percentage (%) calculation. n: Number of subjects who are at the corresponding category. The exact 95% CI for the frequency distribution of each variable were computed using Clopper and Pearson method.CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; CI, confidence interval.